RE: 💣💣 Boom 💣 💣1 Sep 2025 13:26
The new patent filing provides the potential for 20 years of commercial exclusivity for both the diagnostic test and P140 therapy, positioning ImmuPharma as a leader in the next generation of autoimmune disease treatments.
Market Opportunity
Autoimmune diseases affect more than 400 million people worldwide, with a therapeutic market valued at over $100 billion annually. Current treatments remain limited and often unsafe, highlighting a major unmet medical need.
In parallel, the autoimmune diagnostics market represents a rapidly growing opportunity, valued at over $10 billion globally, as healthcare systems increasingly adopt precision diagnostics.